/PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs), today launched.
/PRNewswire/ A first-of-its-kind digital therapeutics research study may offer new hope for patients with a rare lung disease and are having difficulty with.
/PRNewswire/ A first-of-its-kind digital therapeutics research study may offer new hope for patients with a rare lung disease and are having difficulty with.